Rationale and design of the AdaptResponse trial: a prospective randomized study of cardiac resynchronization therapy with preferential adaptive left ventricular‐only pacing

The AdaptResponse trial is designed to test the hypothesis that preferential adaptive left ventricular‐only pacing with the AdaptivCRT(®) algorithm reduces the incidence of the combined endpoint of all‐cause mortality and intervention for heart failure (HF) decompensation, compared with conventional...

Descripción completa

Detalles Bibliográficos
Autores principales: Filippatos, Gerasimos, Birnie, David, Gold, Michael R., Gerritse, Bart, Hersi, Ahmad, Jacobs, Sandra, Kusano, Kengo, Leclercq, Christophe, Mullens, Wilfried, Wilkoff, Bruce L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2017
Materias:
Trial Design
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5606499/
https://www.ncbi.nlm.nih.gov/pubmed/28708290
http://dx.doi.org/10.1002/ejhf.895

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5606499/
https://www.ncbi.nlm.nih.gov/pubmed/28708290
http://dx.doi.org/10.1002/ejhf.895

Ejemplares similares